000 | 01462 a2200409 4500 | ||
---|---|---|---|
005 | 20250512202557.0 | ||
264 | 0 | _c19820924 | |
008 | 198209s 0 0 eng d | ||
022 | _a0141-2760 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJoffe, M I | |
245 | 0 | 0 |
_aA case of Di George syndrome treated with thymopoietin pentapeptide (TP-5) demonstrating an adherent suppressor cell of lymphocyte function. _h[electronic resource] |
260 |
_bJournal of clinical & laboratory immunology _cMay 1982 |
||
300 |
_a69-73 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aB-Lymphocytes |
650 | 0 | 4 | _aCell Adhesion |
650 | 0 | 4 |
_aDiGeorge Syndrome _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xdrug therapy |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aInterleukin-2 _xbiosynthesis |
650 | 0 | 4 | _aLeukocyte Count |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPeptide Fragments _xtherapeutic use |
650 | 0 | 4 | _aRosette Formation |
650 | 0 | 4 |
_aT-Lymphocytes _xclassification |
650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _ximmunology |
650 | 0 | 4 | _aThymopentin |
650 | 0 | 4 |
_aThymopoietins _xtherapeutic use |
650 | 0 | 4 |
_aThymus Hormones _xtherapeutic use |
700 | 1 | _aSochett, E | |
700 | 1 | _aPettifor, J M | |
700 | 1 | _aRabson, A R | |
773 | 0 |
_tJournal of clinical & laboratory immunology _gvol. 8 _gno. 1 _gp. 69-73 |
|
999 |
_c6212704 _d6212704 |